News Article
Oct 8, 2018
ReViral to present at RespiDART 2018

ReViral's Chief Scientific Officer, Stuart Cockerill, will be presenting at RespiDART 2018 in Miami on 29th November 2018. The afternoon session entitled "Therapeutics against respiratory viruses: Clinical advances & industry perspective" begins at 16:25 with ReViral due to present "RV521: A new and potent RSV fusion inhibitor in clinical development" at 17:05.